SLS, IBRX In Focus: Canadian Insurance Giant Manulife’s Unit Raises Stakes Ahead Of Key Cancer Catalysts
Sellas Life Sciences (SLS) and ImmunityBio (IBRX) drew attention on Wednesday after Canadian insurance giant Manulife’s principal operating insurer disclosed that it increased its institutional stakes in both cancer-drug developers during the second quarter.SLS stock snapped a two-session winning s…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.